Literature DB >> 24482781

The utility of human challenge studies in vaccine development: lessons learned from cholera.

Debbie-Ann T Shirley1, Monica A McArthur1.   

Abstract

Experiments in which virulent infectious organisms are administered to healthy adult volunteers with the intent to deliberately induce infection have been practiced for centuries. Many useful applications have developed from these experiments such as the provision of evidence of microbial pathogenicity and the identification of key virulence factors. Challenge studies have also played an important role in the evaluation of preliminary efficacy of potential vaccine candidates. Over the past 40 years, these experimental human challenge studies have found particular utility with regards to the development of both living and nonliving attenuated cholera vaccines. This review highlights some of the important contributions made by these challenge studies to cholera vaccine research.

Entities:  

Keywords:  cholera; human challenge studies; vaccine research; virulent infectious organisms

Year:  2011        PMID: 24482781      PMCID: PMC3904492          DOI: 10.2147/VDT.S23634

Source DB:  PubMed          Journal:  Vaccine (Auckl)        ISSN: 2230-2298


  61 in total

1.  The ethical challenge of infection-inducing challenge experiments.

Authors:  F G Miller; C Grady
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

Review 2.  Typhoid vaccines come of age.

Authors:  M M Levine; D N Taylor; C Ferreccio
Journal:  Pediatr Infect Dis J       Date:  1989-06       Impact factor: 2.129

3.  Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111.

Authors:  C O Tacket; K L Kotloff; G Losonsky; J P Nataro; J Michalski; J B Kaper; R Edelman; M M Levine
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

4.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.

Authors:  M M Levine; J B Kaper; D Herrington; G Losonsky; J G Morris; M L Clements; R E Black; B Tall; R Hall
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  Isolation and characterization of Gal E mutant Ty 21a of Salmonella typhi: a candidate strain for a live, oral typhoid vaccine.

Authors:  R Germanier; E Füer
Journal:  J Infect Dis       Date:  1975-05       Impact factor: 5.226

6.  Vibrio cholerae O139 synonym bengal is closely related to Vibrio cholerae El Tor but has important differences.

Authors:  J A Johnson; C A Salles; P Panigrahi; M J Albert; A C Wright; R J Johnson; J G Morris
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis.

Authors:  S R Attridge; F Qadri; M J Albert; P A Manning
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

8.  Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.

Authors:  J G Morris; G E Losonsky; J A Johnson; C O Tacket; J P Nataro; P Panigrahi; M M Levin
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

Review 9.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

10.  Back to the future: studying cholera pathogenesis using infant rabbits.

Authors:  Jennifer M Ritchie; Haopeng Rui; Roderick T Bronson; Matthew K Waldor
Journal:  MBio       Date:  2010-05-18       Impact factor: 7.867

View more
  14 in total

Review 1.  Will Systems Biology Deliver Its Promise and Contribute to the Development of New or Improved Vaccines? Seeing the Forest Rather than a Few Trees.

Authors:  Mark M Davis; Cristina M Tato
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-08-01       Impact factor: 10.005

2.  Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.

Authors:  Brandon Sit; Bolutife Fakoya; Ting Zhang; Gabriel Billings; Matthew K Waldor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-16       Impact factor: 11.205

Review 3.  Animal models for dissecting Vibrio cholerae intestinal pathogenesis and immunity.

Authors:  Brandon Sit; Bolutife Fakoya; Matthew K Waldor
Journal:  Curr Opin Microbiol       Date:  2021-10-22       Impact factor: 7.934

4.  Vaccine-Mediated Mechanisms Controlling Replication of Francisella tularensis in Human Peripheral Blood Mononuclear Cells Using a Co-culture System.

Authors:  Kjell Eneslätt; Igor Golovliov; Patrik Rydén; Anders Sjöstedt
Journal:  Front Cell Infect Microbiol       Date:  2018-02-07       Impact factor: 5.293

5.  Exploring the acceptability of controlled human infection with SARSCoV2-a public consultation.

Authors:  D Gbesemete; M Barker; W T Lawrence; D Watson; H de Graaf; R C Read
Journal:  BMC Med       Date:  2020-07-07       Impact factor: 8.775

6.  Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection.

Authors:  Rachel Tanner; Iman Satti; Stephanie A Harris; Matthew K O'Shea; Deniz Cizmeci; Daniel O'Connor; Agnieszka Chomka; Magali Matsumiya; Rachel Wittenberg; Angela M Minassian; Joel Meyer; Helen A Fletcher; Helen McShane
Journal:  Front Immunol       Date:  2020-01-10       Impact factor: 7.561

Review 7.  A review of clinical models for the evaluation of human TB vaccines.

Authors:  Matthew K O'Shea; Helen McShane
Journal:  Hum Vaccin Immunother       Date:  2016-01-25       Impact factor: 3.452

8.  An Evidenced-Based Scale of Disease Severity following Human Challenge with Enteroxigenic Escherichia coli.

Authors:  Chad K Porter; Mark S Riddle; Ashley N Alcala; David A Sack; Clayton Harro; Subhra Chakraborty; Ramiro L Gutierrez; Stephen J Savarino; Michael Darsley; Robin McKenzie; Barbara DeNearing; Hans Steinsland; David R Tribble; A Louis Bourgeois
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

9.  A framework for Controlled Human Infection Model (CHIM) studies in Malawi: Report of a Wellcome Trust workshop on CHIM in Low Income Countries held in Blantyre, Malawi.

Authors:  Stephen B Gordon; Jamie Rylance; Amy Luck; Kondwani Jambo; Daniela M Ferreira; Lucinda Manda-Taylor; Philip Bejon; Bagrey Ngwira; Katherine Littler; Zoe Seager; Malick Gibani; Markus Gmeiner; Meta Roestenberg; Yohannie Mlombe
Journal:  Wellcome Open Res       Date:  2017-08-24

Review 10.  Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections.

Authors:  Isabelle Bekeredjian-Ding
Journal:  Front Immunol       Date:  2020-08-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.